Hung, P.-H.; Hsu, Y.-C.; Chen, T.-H.; Ho, C.; Lin, C.-L.
The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation. Int. J. Mol. Sci. 2022, 23, 9407.
https://doi.org/10.3390/ijms23169407
AMA Style
Hung P-H, Hsu Y-C, Chen T-H, Ho C, Lin C-L.
The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation. International Journal of Molecular Sciences. 2022; 23(16):9407.
https://doi.org/10.3390/ijms23169407
Chicago/Turabian Style
Hung, Peir-Haur, Yung-Chien Hsu, Tsung-Hsien Chen, Cheng Ho, and Chun-Liang Lin.
2022. "The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation" International Journal of Molecular Sciences 23, no. 16: 9407.
https://doi.org/10.3390/ijms23169407
APA Style
Hung, P.-H., Hsu, Y.-C., Chen, T.-H., Ho, C., & Lin, C.-L.
(2022). The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation. International Journal of Molecular Sciences, 23(16), 9407.
https://doi.org/10.3390/ijms23169407